Transgene SA (EPA:TNG)
France · Delayed Price · Currency is EUR 1.335
+0.045 (3.49%)
Oct 20, 2025, 1:44 PM CET
Transgene Market Cap
Transgene has a market cap or net worth of €170.76 million as of October 20, 2025. Its market cap has increased by 8.72% in one year.
Market Cap
170.76M
Enterprise Value
185.06M
Revenue
7.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.34
Market Cap Chart
Since March 30, 1998, Transgene's market cap has increased from 151.86M to 170.76M, an increase of 12.45%. That is a compound annual growth rate of 0.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 170.76M | 90.26% |
| Dec 31, 2024 | 89.75M | -34.86% |
| Dec 29, 2023 | 137.78M | -16.38% |
| Dec 30, 2022 | 164.76M | -33.52% |
| Dec 31, 2021 | 247.84M | 79.73% |
| Dec 31, 2020 | 137.90M | 6.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 127.55B |
| Sanofi | 105.05B |
| Sartorius Stedim Biotech | 19.84B |
| bioMérieux | 13.01B |
| Eurofins Scientific SE | 11.26B |
| Ipsen | 9.41B |
| ABIVAX Société Anonyme | 6.13B |
| Virbac | 2.61B |